Drug search by name

Alemtuzumab and Cardiac/pulmonary disease

Result of checking the interaction of drug Alemtuzumab and disease Cardiac/pulmonary disease for safety when used together.

Check result:

Alemtuzumab <> Cardiac/pulmonary disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of alemtuzumab can cause severe infusion reactions, including pyrexia, chills/rigors, nausea, hypotension, urticaria, dyspnea, rash, emesis, and bronchospasm. Caution should be taken in patients with a history of pulmonary disease, heart disease as they may require dose-escalation and additional pre-infusion medications to manage complications as appropriate.

Alemtuzumab

Generic Name: alemtuzumab

Brand Name: Campath, Lemtrada

Synonyms: n.a.

What is Alemtuzumab?